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2 
Abstract 14 
This study examined the relationship between specific molecular features of trace organic 15 
contaminants and their removal efficiencies by a laboratory scale membrane bioreactor (MBR). 16 
Removal efficiencies of 40 trace organic compounds were assessed under stable operating 17 
conditions. The reported results demonstrate an apparent correlation between chemical structures 18 
and the removal of trace organic contaminants by the laboratory scale MBR system. The removal 19 
of all 14 very hydrophobic trace organic compounds (Log D > 3.2) selected in this study was 20 
consistently high and was above 85%. The occurrence and types of electron withdrawing or 21 
donating functional groups appears to be another important factor governing their removal by 22 
MBR treatment. In this study, all hydrophilic and moderately hydrophobic (Log D < 3.2) 23 
compounds possessing strong electron withdrawing functional groups showed removal 24 
efficiency of less than 20%. In contrast, high removal efficiencies were observed with most 25 
compounds bearing electron donating functional groups such as hydroxyl and primary amine 26 
groups. A qualitative framework for the assessment of trace organic removal by MBR treatment 27 
was proposed to provide further insights into the removal mechanisms of trace organic 28 
contaminants by MBR treatment. 29 
Keywords: membrane bioreactor (MBR), trace organic contaminants, sorption, biodegradation 30 
molecular structure, hydrophobicity. 31 
32 
3 
1 Introduction 33 
Major driving forces toward water recycling today are the growing demand for water from an 34 
increasing population, changing lifestyle patterns, urbanisation, and diminishing natural water 35 
resources. In addition, better public awareness about environmental protection has resulted in 36 
progressively more stringent wastewater quality discharge regulations. Despite the growing 37 
interest in water recycling, our predictive capacity regarding the ability of treatment technologies 38 
to remove specific trace organic contaminants remains very limited. This is reflected by the 39 
public reluctance to accept reclaimed water for potable reuse and the fact that most water 40 
recycling applications are currently still restricted to non-potable purposes.  41 
Membrane bioreactors (MBRs) have recently emerged as an important technology for water 42 
recycling, capable of transforming wastewater to high quality effluent suitable for various water 43 
recycling applications (Atkinson, 2006). Becoming commercially available only around two 44 
decades ago, MBR technology has already been well proven and can provide a superior rating 45 
for most bulk water quality indicators such as pathogens, suspended solids and nutrient removal 46 
compared to conventional activated sludge (CAS) treatment processes (Melin et al., 2006; 47 
Visvanathan et al., 2000). However, the efficiency of MBR technology as a barrier for a range of 48 
trace organic contaminants such as endocrine disrupting chemicals (EDCs), pesticides, and 49 
pharmaceutically active compounds (PhACs), as well as the specific removal mechanisms 50 
involved remain unclear (Clara et al., 2005; De Wever et al., 2007; Kimura et al., 2005; Qu et al., 51 
2009; Visvanathan et al., 2005; Wintgens et al., 2004). Previous studies have indicated 52 
significant variation in the removal of trace organics by MBRs, ranging from near complete 53 
removal for some compounds (e.g. ibuprofen and bezafibrate) to almost no removal for several 54 
others (e.g. carbamazepine and diclofenac) (Clara et al., 2005; Kimura et al., 2005; Tadkaew et 55 
al., 2010; Urase et al., 2005). The reasons for such variation are not yet fully understood.  56 
Physicochemical properties of trace organics have been reported to significantly govern the 57 
removal efficiency by MBR treatment. Biosorption of trace contaminants driven primarily by 58 
hydrophobic interaction appears to be one of the key mechanisms controlling removal efficiency 59 
in MBR. For instance, apparent improvement in removal efficiency of certain acidic trace 60 
organics such as ibuprofen, ketoprofen, and diclofenac has been observed when MBRs are 61 
operated under acidic conditions rather than neutral conditions (Tadkaew et al., 2010; Urase et 62 
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al., 2005). This phenomenon was explained by the speciation of the compounds from hydrophilic 63 
ionic forms to much more hydrophobic forms at pH lower than their pKa values.  64 
A limited number of studies has shed some light on the effect of chemical structures on the 65 
removal efficiency of trace chemicals during biological treatment processes. For example, 66 
Kimura et al., (2005) attributed the poor removal of clofibric acid, diclofenac, and dichloprop to 67 
the presence of chlorine in their molecular structure or their relatively complicated aromatic 68 
rings. Several studies have utilised the US-EPA-developed Biodegradation Probability Program 69 
for Windows (BIOWIN) software package which is one of the most widely used quantitative 70 
structure biodegradability relationship (QSBR) computer-based programs to estimate the 71 
biodegradability of organic compounds under aerobic conditions. Lapertot and Pulgarin 72 
investigated the biodegradability of 17 priority hazardous substances and suggested that the 73 
primary and ultimate BIOWIN models were generally suitable for removal assessment of these 74 
compounds in industrial wastewater treatment processes (Lapertot and Pulgarin, 2006). On the 75 
other hand, Yu et al., (2006) reported some inconsistency between the likelihood of 76 
biodegradability predicted by BIOWIN and experimental data when they investigated the 77 
removal efficiency of 18 pharmaceutical and personal care products at a conventional municipal 78 
wastewater treatment plant (Yu et al., 2006).  79 
Although the connection between chemical structure and removal efficiency seems highly 80 
plausible, studies to develop a capacity to predict the removal efficiency of trace organic 81 
contaminants by MBR treatment processes based on a range of molecular parameters are still 82 
limited. Because of the involvement of the many diverse and complex functional groups, the 83 
connection between chemical structure and removal efficiency has not yet been thoroughly 84 
examined in the literature. In fact, several previous attempts to identify a definitive relationship 85 
between the structures of trace organic contaminants and their removal efficiencies during CAS 86 
and MBR treatment have been unsuccessful (Joss et al., 2005; Radjenovic et al., 2007). 87 
This study aimed to elucidate the connection between specific molecular features of trace 88 
organic contaminants and their removal efficiencies by a laboratory scale MBR. The MBR 89 
system was operated under stable conditions for an extended period to allow for a systematic 90 
examination of the removal of 40 trace organic contaminants at environmentally relevant 91 
concentrations. Hydrophobicity and molecular structures of the selected trace organic 92 
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compounds were carefully delineated and correlated to their removal efficiencies. Key factors 93 
governing the removal efficiencies of trace organic contaminants were identified and reported. 94 
2 Materials and methods 95 
2.1. Laboratory scale MBR system 96 
A laboratory-scale MBR system was used in this study. Detailed description of this MBR system 97 
is available elsewhere (Tadkaew et al., 2010). The system consisted of a glass reactor, a 98 
continuous mixer, two air pumps, a pressure sensor, and influent and effluent pumps. Two 99 
ZeeWeed-1 (ZW-1) submerged hollow fibre ultrafiltration membrane modules supplied by 100 
Zenon Environmental (Ontario, Canada) were used in this set-up. The membrane has a nominal 101 
pore size of 0.04 µm. Each module has an effective membrane surface area of 0.047 m2. A 102 
Neslab RTE 7 equipped with a stainless steel heat exchanging coil was used to maintain a 103 
constant temperature in the MBR. A personal computer was used to control the permeate 104 
peristaltic pump to operate on a 14 minute suction and 1 minute off cycle to provide relaxation 105 
time to the membrane modules. Flow rate of the influent pump was matched with that of the 106 
permeate pump to maintain a constant reactor volume. The continuous mixer was used to ensure 107 
homogeneous conditions of the mixed liquor and to prevent the settling of biomass. 108 
2.2. Synthetic wastewater 109 
A synthetic wastewater simulating municipal sewage was used to ensure a stable feeding rate 110 
throughout the experiment. Concentrated stock solution was prepared and stored in a refrigerator 111 
at 4 oC. It was then diluted with MilliQ water on a daily basis to make up a feed solution 112 
containing glucose (400 mg/L), peptone (75 mg/L), KH2PO4 (17.5 mg/L), MgSO4 (17.5 mg/L), 113 
FeSO4 (10 mg/L), and sodium acetate (225 mg/L). This composition was based on a previous 114 
study (Zhang et al., 2006). 115 
2.3. Trace organic compounds 116 
In this study, 40 organic compounds were selected to represent four major trace organic groups 117 
of concern in water reuse applications – namely pesticides, pharmaceutically active compounds, 118 
steroid hormones, and other endocrine disrupting chemicals. The selection of these model trace 119 
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organic compounds was also based on their widespread occurrence in domestic sewage and their 120 
diverse physicochemical properties (e.g. hydrophobicity and molecular weight). The effective 121 
hydrophobicity of these compounds varies significantly as reflected by their Log D values at pH 122 
8 (see supplementary data) which is typical of an activated sludge reactor (Wells, 2006). The 123 
most hydrophilic compound is enalapril with Log D at pH 8 of –1.21 and the most hydrophobic 124 
compound is nonylphenol with Log D at pH 8 of 6.19. All selected trace organic compounds 125 
were of analytical grade. A combined stock solution was prepared in pure acetonitrile. The trace 126 
organic stock solution was kept in a freezer and was used within less than a month.  127 
2.4. Analytical techniques 128 
The analysis of the model trace organics was based on a previously reported method (Tadkaew et 129 
al., 2010; Vanderford and Snyder, 2006). Analytes were extracted using 5 mL, 500 mg solid 130 
phase extraction hydrophilic/lipophilic balance (HLB) cartridges (Waters, Millford, MA, USA). 131 
Samples were spiked with a solution containing 50 ng of an isotopically labeled version of each 132 
analyte. The sample was then loaded onto the cartridges at 15 mL/min, after which the cartridges 133 
were rinsed with 5 mL of reagent water and dried with a stream of nitrogen for 30 min. Loaded 134 
cartridges were stored at – 4 °C in sealed bags until elution and analysis.  135 
Analytes were separated using an Agilent (Palo Alto, CA, USA) 1200 series high performance 136 
liquid chromatography (HPLC) system equipped with a 150 x 4.6 mm, 5 µm particle size, Luna 137 
C18 (2) column (Phenomenex, Torrence CA, USA). Mass spectrometry was performed using an 138 
API 4000 triple quadrupole mass spectrometer (Applied Biosystems, Foster City, CA, USA) 139 
equipped with a turbo-V ion source employed in both positive and negative electro-spray modes.  140 
Steroid hormones were analysed using an atmospheric pressure chemical ionisation method and 141 
all other compounds were analysed using an electro-spray ionisation method. For each analyte 142 
and internal standard a precursor ion and two product ions were monitored for reliable 143 
confirmation.  Relative retention times of the analyte and isotopically labeled internal standard 144 
were also monitored to ensure correct identification (Vanderford and Snyder, 2006).  145 
Standard solutions of all analytes were prepared at 1, 5, 10, 50, 100, 500 and 1000 ng/mL.  A 146 
relative response ratio of analyte/internal standard over a 1 – 1000 ng concentration range was 147 
generated enabling quantification with correction for losses due to ion suppression and 148 
7 
incomplete SPE recovery.  All calibration curves had a correlation coefficient of 0.99 or better. 149 
The limit of reporting was determined using an s/n ratio of greater than 10.   150 
Conductivity and pH were measured using an Orion 4-Star Plus pH/conductivity meter. Total 151 
organic carbon (TOC) and total nitrogen (TN) were analysed using a Shimadzu TOC/TN-VCSH 152 
analyser. TOC analysis was conducted in non-purgeable organic carbon (NPOC) mode. Samples 153 
were kept at 4°C until analysed and calibrations were performed in the range between 0 and 1000 154 
mg/L and 0 to 100 mg/L for TOC and TN, respectively. Mixed liquor suspended solid (MLSS) 155 
and mixed liquor volatile suspended solid (MLVSS) contents in the MBR were measured in 156 
accordance to the Standard Methods for the Examination of Water and Wastewater (Clescerl et 157 
al., 2005). 158 
2.5. MBR experimental protocol 159 
The MBR was seeded with activated sludge from the Wollongong sewage treatment plant, NSW, 160 
Australia. After the initial start-up process, which lasted about 2 months, a small amount of 161 
sludge was regularly extracted from the reactor to keep the sludge age at approximately 70 days. 162 
The hydraulic retention time was set at 24 hours, corresponding to a permeate flux of 4.3 L/m2h. 163 
The MBR temperature and dissolved oxygen content were kept constant at 20.0±0.1oC and 2±1 164 
mg/L, respectively. Performance of the MBR system with regard to basic water quality 165 
parameters was then monitored for an extended period of more than four weeks.  166 
Once stable operation had been achieved, trace organic contaminants were continuously 167 
introduced into the feed solution to make up a concentration of approximately 2 µg/L of each 168 
selected compound. The investigation with trace organics was over a period of four weeks during 169 
which no sludge was withdrawn from the reactor. The feed solution was kept in a stainless steel 170 
reservoir at controlled room temperature (20±2 oC). Feed and permeate samples were taken twice 171 
a week in duplicate and solid phase extraction was conducted immediately for subsequent trace 172 
organic analysis. Removal efficiency was calculated as  InfEff CCR /1100  , where CEff and 173 
CInf are effluent (permeate) and influent concentrations (ng/L) of the trace organic compound, 174 
respectively. It is noted that complete degradation of an organic compound may follow different 175 
pathways and undergo several steps. Therefore, the term removal here does not necessarily 176 
indicate complete degradation of the trace organics, but rather a loss of the specific trace 177 
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chemical molecule. In many cases, stable intermediates or ‘metabolites’ may be produced, but 178 
detailed consideration of these intermediates is beyond the scope of the current study. 179 
3 Results and discussion 180 
3.1. Performance stability of the MBR 181 
In this study, synthetic feed solution was used to ensure a consistent influent composition. The 182 
MBR showed stable and good performance with respect to all key water quality parameters. The 183 
stable performance continued even following the introduction of the trace organic contaminants 184 
to the feed solution. A notable exception, however, was a significant decline in the removal of 185 
total nitrogen (TN) immediately after the introduction of the trace organic contaminants from 186 
almost complete removal to as low as 60%. The decrease in TN removal can be explained by the 187 
introduction of acetonitrile, the solvent used to introduce the trace organics, to the influent. The 188 
MBR system used in this study was operated under aerobic conditions and therefore is not 189 
expected to have any biological denitrification capacity. The synthetic feed solution was 190 
deficient in nitrogen, and therefore, the initial high TN removal observed here could be attributed 191 
to the conversion of dissolved organic nitrogen to biomass, which would then be retained by the 192 
membrane. Because acetonitrile was used as a carrying solvent for the introduction of the trace 193 
organic contaminant cocktail into the feed solution, the introduction of trace organic 194 
contaminants into the feed solution resulted in a significant increase in TN in the influent from 195 
12 mg/L to approximately 49.5 mg/L. This was assumed to be the main reason for the observed 196 
decrease in TN removal. The increase in nitrogen content of the feed water did not exert any 197 
discernible impact on any other biological performance indicators of the MBR system. There 198 
was a slight increase in the MLSS content in the reactor from 8.6 g/L to 10.0 g/L over the 199 
duration of the experiment of approximately one month while the MLVSS/MLSS ratio remained 200 
constant at approximately 0.9. Other basic performance parameters including TOC removal 201 
efficiency (98%), pH of the MLSS (7.5±0.1), effluent conductivity (559±19 µS/cm) were also 202 
relatively stable during the entire experiment . In addition, no abnormal transmembrane pressure 203 
increase was observed following the introduction of the trace contaminants to the feed solution 204 
(data not shown).  205 
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Stable performance of the MBR system could also be observed with respect to the removal of 206 
trace organic contaminants (Figure 1). It is noted that the error bars shown in Figure 1 represent 207 
the standard deviations of eight influent and effluent samples, regularly collected in replicate 208 
throughout the experiment. It is also notable that the removal efficiencies of the 40 compounds 209 
investigated in this study vary significantly ranging from negligible removal (e.g.: atrazine, 210 
carbamazepine, dilatin, and trimethoprim) to removal to below the analytical detection limit 211 
(e.g.: 17β-estradiol, testosterone, and triclocarban), indicating a removal of at least 98%. The 212 
observed significant variation in the removal efficiency of the trace organic contaminants by 213 
MBR treatment indicates that improved understanding of the key factors that govern the 214 
elimination of specific chemicals is required to enable prediction of MBR treatment performance 215 
for any particular chemical or class of chemicals. 216 
[FIGURE 1] 217 
3.2. Removal of trace organic contaminants 218 
A logical approach to qualitatively predict the effectiveness of MBR treatment for the removal of 219 
a wide range of trace organic contaminants is to evaluate their removal efficiency according to 220 
the intended applications or origins of these compounds. Accordingly, Table 1 summarises the 221 
removal efficiencies of the 40 compounds selected in this study. Data previously reported in 222 
other studies, whenever available, are also included for comparison purposes. With caffeine 223 
being the only noteworthy exception, results reported here are in good agreement with the 224 
literature data. The mean removal efficiency of caffeine observed in our study is 49.6 %, which 225 
is substantially lower than the previously reported values (Kim et al., 2007; Snyder et al., 2007). 226 
In a recent study, Santos et al., (2009) examined the performance of four CAS wastewater 227 
treatment plants in Seville city (Spain). They reported a highly variable caffeine removal 228 
efficiency among these four treatment plants with the mean value ranging from as low as 44% up 229 
to 75% (Santos et al., 2009). Given the similarity between MBR and CAS treatment, it is 230 
possible that this discrepancy can be explained by the differences in operating conditions. The 231 
literature data presented in Table 1 are from a range of sources with different operating 232 
conditions and system arrangements. The reported experimental results confirm that the MBR 233 
system used in this study behaved well within the range of typical performance data from other 234 
systems. Therefore, the results presented in this study and the conclusion drawn from them 235 
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would be broadly applicable and generalisable to most typical MBR systems. In fact, data 236 
presented in Table 1 suggest that some generalisation can be made about certain groups of 237 
compounds. 238 
[TABLE 1] 239 
All the three pesticides investigated in this study showed very low removal efficiencies. 240 
Atrazine, a chloro-triazine herbicide, was removed at a rate of less than 5%. It has been reported 241 
to be poorly removed both in CAS and MBR (Bernhard et al., 2006) and that a major removal 242 
mechanism was sorption onto withdrawn sludge (Bouju et al., 2008). Linuron is a dichloro-243 
phenylurea herbicide.  Despite being a widely used herbicide, no reports on the removal of 244 
Linuron in CAS or MBR could be found. However, its slow natural attenuation rate in various 245 
soils and the evolution of more toxic and persistent chloroaniline intermediates in the process 246 
have been reported (Dejonghe et al., 2003). A mean removal of 21% of linuron as achieved in 247 
our MBR, therefore, appears to be consistent with the reported recalcitrance of this compound. 248 
DEET is a toluamide compound and is the most common active ingredient in insect repellants. In 249 
this study, a mean removal of 4.6% of DEET was recorded during MBR treatment. This removal 250 
efficiency is at the lower end of range reported in other published studies. Bernhard et al., (2006) 251 
reported nil to over 50% removal of DEET by MBR treatment and suggested that DEET removal 252 
efficiency was dependent on the sludge retention time. Kim et al. (Kim et al., 2007) reported no 253 
removal of DEET in their study; however, no information about the SRT was provided. The 254 
highest removal efficiency of DEET of 78% was reported by Snyder et al., calculated from a one 255 
off sampling event at a pilot scale treatment facility (Snyder et al., 2007).  256 
Near complete removal or removal to below the analytical limit of all eight steroid hormones and 257 
three other EDCs selected for investigation (bisphenol A, nonylphenol, and t-octylphenol) were 258 
observed in this study. These results are consistent with other published studies (Table 1). It is 259 
noteworthy that all of these compounds possess significant hydrophobicity and bear a similar 260 
molecular backbone structure; which may, in part, explain the similarities of their removal 261 
efficiencies. 262 
No generalistion can be inferred for any of the six therapeutic classes of pharmaceuticals 263 
investigated in this study (Table 1). Their removal efficiencies by MBR treatment vary widely 264 
even within the same class of compounds. The removal efficiencies of the five non-steroidal 265 
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anti-inflammatory drugs (NSAIDs) differ remarkably from one another. For example, ibuprofen 266 
registers a removal efficiency of 97% whereas the removal efficiency of diclofenac is only 17%. 267 
Unlike the other NSAIDs, diclofenac is a chlorinated compound, which can possibly explain its 268 
recalcitrant behavior in MBR treatment. Significant variation in the removal efficiency can also 269 
be observed among compounds used as anti-depressants and mood stabilizers. Dilantin, 270 
primidone and carbamazepine were poorly removed, whereas the removal efficiencies of 271 
clozapine, risperidone, and amitriptyline were 85% and higher. Given the considerable 272 
dissimilarity in the molecular structure among these anti-depressants and mood stabilizers, 273 
differences in their removal efficiencies can be expected. Further analysis of the molecular 274 
structures of these compounds is presented in section 3.3.2. Significant variation in removal 275 
efficiency was observed among the other pharmaceutical groups (cardiovascular and other drugs) 276 
and can again be attributed to their diverse molecular structures (Table 1 and supplementary data 277 
1). Among the hypolipidemic agents (lipid lowering drugs) investigated in this study, simvastatin 278 
is a hydrophobic compound with Log D (at pH 8) of 4.41 and the compound registers a removal 279 
efficiency of 98% (Table 1). Simvastatin hydroxyacid) shares the same molecular backbone 280 
structure with that of simvastatin. However, the 3, 5–dihydroxy–heptanoic acid functional group 281 
of simvastatin hydroxyacid renders the compound much more hydrophilic (Log D at pH 8 of 282 
0.64). Consequently, simvastatin hydroxyacid shows a much lower removal efficiency of 60% in 283 
comparison to that of the related compound simvastatin.   284 
Results reported in Table 1 suggest that the classification of trace organics according to their 285 
intended use or origin can only be used to qualitatively predict the removal efficiencies of 286 
compounds of similar molecular structure, having similar molecular features or physicochemical 287 
properties. In fact, certain molecular features and physicochemical properties of the trace organic 288 
contaminants appear to be the underlying factors governing their rate of removal during MBR 289 
treatment. 290 
3.3. Role of molecular features 291 
Attempts to fit the removal efficiency data obtained in our study and the corresponding available 292 
biodegradability scores from BIOWIN model  did not result in any meaningful correlations (data 293 
not shown). Although this result is somewhat surprising, it does not necessarily invalidate the 294 
model. BIOWIN is essentially a statistical model and the discrepancies may have arisen to some 295 
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extent due to the fact that the BIOWIN scores were derived from batch tests, which cannot 296 
effectively replicate the biological conditions of an MBR. It is also noteworthy that only three 297 
out of 40 compounds investigated in this study were included in the database which has been 298 
used for the development of BIOWIN. Furthermore, BIOWIN would not account for the 299 
adsorption of trace organics to biosolids which can be an important removal mechanism along 300 
with biodegradation. Given the poor correlation between the removal efficiencies experimentally 301 
obtained in this study and the BIOWIN biodegradability scores, it is necessary to further 302 
examine the key physicochemical properties and molecular features that can govern the removal 303 
efficiency of trace organic compounds. 304 
3.3.1 Effects of hydrophobicity 305 
The removal of trace organic contaminants by an activated sludge treatment process is a complex 306 
function of both sorption and biological degradation. In a CAS treatment process, the sludge-307 
bound contaminants can be subsequently removed via sludge withdrawal. In addition, sorption of 308 
trace organic contaminants to biosolids results in a longer residence time in the reactor, which 309 
may lead to further removal via biodegradation. Because the MLSS content and sludge retention 310 
time of typical MBR processes are much higher than those of CAS treatment, sorption has been 311 
suggested as a major removal mechanism for the removal of trace organic contaminants by MBR 312 
treatment. In a systematic survey of the literature data, Wells suggested that the sorption of a 313 
trace organic contaminant to the activated sludge could be assessed by considering the Log D 314 
value of the compound at a given pH (Wells, 2006). Experimental results presented in Figure 2 315 
indicate that this finding can be extended to MBR treatment. There appears to be a ‘removal 316 
envelop’ that can be defined by the hydrophobicity of the trace organic contaminants (Figure 2). 317 
Removal of the very hydrophobic (Log D > 3.2) compounds is probably dominated by sorption 318 
to the activated sludge facilitating enhanced biological degradation in some cases. Therefore, 319 
these compounds consistently showed high removal efficiency (above 85%). As the Log D value 320 
of the compounds decreased to below 3.2, sorption of these trace organic contaminants onto the 321 
activated sludge was no longer a dominating removal mechanism and the removal efficiency of 322 
these compounds is much more strongly influenced by their intrinsic biodegradability. As a 323 
result, the removal efficiency of trace organics with low Log D values (at pH 8) varies 324 
significantly from less than 20% to removal to below the analytical detection limit 325 
(corresponding to a removal of at least 98%). Of particular note in Figure 2 is a cluster of five 326 
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compounds that show very low removal efficiencies despite their moderately high 327 
hydrophobicity (Log D in the rage from 2 to 3.2). It is also noteworthy that all five compounds 328 
possess one or several electron withdrawing functional groups, such as a chlorine atom or amide 329 
group. Results reported here suggest that individual molecular features can also be an important 330 
factor governing the removal efficiency of trace organics during MBR treatment.   331 
[FIGURE 2] 332 
3.3.2 Effects of molecular weight 333 
The molecular weights of the trace organics studied here ranged from 151 g/mol (paracetamol) to 334 
455 g/mol (verapamil). There appears to be a weak but nevertheless discernible correlation 335 
between the removal efficiency of these trace organics and their molecular weights (Figure 3). 336 
Compounds with molecular weight of more than 300 g/mol were relatively well removed 337 
(>60%), while the removal efficiencies those with molecular weight of less than 300 g/mol 338 
varied from almost no removal to more than 98% (removal beyond the analytical detection 339 
limit). A plausible explanation for this observation could be the relative hydrophobicity (log D at 340 
pH 8 in the range from 2.03 to 5.74, see supplementary data) of the compounds having molecular 341 
weight of more than 300 g/mol. In addition, in this study, removal efficiency does not necessarily 342 
represent a complete mineralisation of the compound. Compounds with higher molecular weight 343 
may have more branches, which would offer more opportunities for the microbes to selectively 344 
cleave a certain target site and initiate degradation. 345 
 [FIGURE 3] 346 
3.3.3 Effect of chemical structure 347 
Experimental results obtained in this study confirm the possible role of molecular functional 348 
groups in governing the removal of moderately hydrophobic and hydrophilic trace organic 349 
compounds by MBR treatment. The 40 trace organic compounds investigated in this study can 350 
be systematically categorized into three groups. Group A consists of compounds with Log D at 351 
pH 8 of above 3.2. As discussed above, sorption was a dominant removal mechanism for these 352 
hydrophobic compounds and the removal efficiencies of all compounds of group A were above 353 
85% (Figure 2). To further elucidate the role of different molecular features, the rest of the 354 
compounds can be categorised in terms of ring structure (heterocyclic/ non-heterocyclic, mono 355 
or polynuclear) and functional groups (electron withdrawing/donating moieties). Figure 4 shows 356 
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the removal efficiency as a function of ring structure, whereas Figure 5 presents the compounds 357 
under three distinct categories (B, C and C*) based on the presence and types of electron 358 
withdrawing or donating functional groups. 359 
[FIGURE 4] 360 
[FIGURE 5] 361 
No clear distinction between heterocyclic or non-heterocyclic compounds removal could be 362 
observed in this study (Figure 4). Similarly, no discernible trend in terms of mononuclear or 363 
polynuclear compound could be observed. It is generally considered that simple aliphatic and 364 
monocyclic aromatic compounds are readily degradable, while polycyclic structures may be 365 
more persistent (Jones et al., 2005).  However, irrespective of the mono or polynuclear structure, 366 
degradation can initiate by the mere cleavage of a side chain structure and then further 367 
mineralisation may depend on the complexity of the nucleus. In this study, removal indicates the 368 
loss of the parent structure, and not complete mineralisation. Therefore, the absence of any 369 
discernible correlation between the removal efficiency and ring structure is not entirely 370 
unexpected.   371 
As shown in Figure 4, the compounds containing strong electron withdrawing groups (B) 372 
consistently showed very low (<20%) removal efficiency. According to Knackmuss 373 
(Knackmuss, 1996), the initial electrophilic attack by oxygenases of aerobic bacteria is often a 374 
rate-limiting step and the first of a chain of reactions responsible for the biodegradation of many 375 
organic compounds. As a result, the presence of electron withdrawing functional groups 376 
generates an electron deficiency and thus renders the compounds less susceptible to oxidative 377 
catabolism.  Electron donating functional groups, on the other hand, render the molecules more 378 
prone to electrophilic attack by oxygenases of aerobic bacteria. Consequently, the removal 379 
efficiencies of organic compounds bearing strong electron donating functional groups were, in 380 
most cases, much higher than those of group B in Figure 4. The removal of the compounds 381 
containing both electron withdrawing and donating groups however showing less than 70% 382 
removal have been placed in group C*. 383 
The elucidation of the overall influence of these functional groups and particularly their 384 
opposing effects on the biodegradability of trace organic compounds is a complex task and 385 
would generally require extensive exercise involving simultaneous application of quantitative 386 
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structure activity relationship and biochemical interpretation, as demonstrated for a particular 387 
compound class (N-heterocycles) by Philipp et al. (2007) . Because a large number of diverse 388 
compound classes were studied here, such a rigorous approach falls beyond the scope of this 389 
paper. Nevertheless some general inference, can be drawn from the results in the light of 390 
metabolic pathway information retrieved from the sparse literature and also from biodegradation 391 
prediction tools such as UM-BBD PPS (Wackett and Ellis, 1999). 392 
The biodegradation of amide-only compounds needs to proceed from conversion of the amide 393 
group to primary amine (Hart and Orr, 1975). As suggested by the low removal of 394 
carbamazepine and dilantin, this pathway appears to be extraordinarily recalcitrant. All the tested 395 
compounds possessing only methyl (weak electron donor) and amide (strong electron 396 
withdrawing) groups including primidone, DEET and meprobamate were very poorly removed. 397 
The presence of methyl groups means that the degradation could initiate from conversion of the 398 
methyl group to alcohol (Shaw and Harayama, 1992), bypassing the recalcitrant amide 399 
conversion. However, methyl and other aliphatic groups have very weak electron donating 400 
capacity, and thus in presence of a strong electron withdrawing group they may have limited 401 
activating effect.  402 
All three compounds (i.e. atenolol, enalapril and caffeine) containing both the amine (strong 403 
electron donating) and the amide (strong electron withdrawing) functional groups were quite 404 
well removed (50-97%). Degradation of compounds with amine group may proceed by 405 
converting the existing amine to a less substituted form of amine and aldehyde/ketone (Hakil et 406 
al., 1998). Comparing the performance of these three compounds (containing amide and amine 407 
groups) with that of primidone, DEET and meprobamate (containing amide and methyl groups), 408 
it appears that the co-existence of the amine, and not the methyl group, with the amide group 409 
may make these compounds more amenable to biodegradation. The excellent removal of another 410 
amide-containing compound paracetamol can be attributed to the presence of the hydroxyl group 411 
which is also a strong electron donating functional group. In this context, it is noteworthy that the 412 
entire set of hydroxyl group-containing compounds tested in this study showed high removal. 413 
Such positive impact of hydroxyl group on biodegradation is in line with the literature reports 414 
(Tunkel et al., 2000). 415 
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Halogenated organics comprise a superset which has many antimicrobial as well as human toxic 416 
and carcinogenic industrial chemicals as members (Häggblom and Bossert, 2004). Linuron 417 
contains both halogen and amide groups and accordingly demonstrated low removal.  418 
Interestingly, of the halogenated compounds with amine group, risperidone (containing amine, 419 
methyl and amide) and hydroxyzine (containing amine and hydroxyl) showed good removal 420 
while diclofenac (containing amine and carboxylic) and atrazine (containing amine and methyl) 421 
showed poor removal. Literature review regarding the metabolic pathways of these compounds 422 
provided further insights but could not resolve the paradox. It is suggested in the literature that 423 
the metabolism of hydroxyzine can proceed simultaneously through the conversion of amine to 424 
aldehyde/ketone or through oxidation of the alcohol moiety to a carboxylic acid (Campoli-425 
Richards et al., 1990). In case of risperidone the degradation may initiate via 9-hydroxylation 426 
and/or via N-dealkylation at the piperadine nitrogen (Mannens et al., 1993). Diclofenac has been 427 
suggested to be degraded by hydroxylation of the 1-amino-2-unsubstituted aromatic fragment 428 
(Marco-Urrea et al., 2010). The degradation of atrazine, on the other hand, has been reported to 429 
be initiated through N-monodealkylation, hydroxylation of the isopropyl or tert-butyl moiety 430 
(Lang et al., 1996) or in the rare case via oxidation of the s-triazine ring to hydroxy-s-triazine 431 
(De Souza et al., 1995). While it is certain that the aerobic oxidation of the halogenated 432 
compounds initiate from the co-existing electron withdrawing groups and not via 433 
dehalogentaion, it is not clear why despite seemingly similar metabolic pathways (e.g., 434 
hydroxylation, dealkylation) the compounds exhibit different extents of recalcitrance. 435 
Notably hydroxylation of the vicinal unsubstituted aromatic fragment and the mono-carbon-436 
substituted benzenoid are the predominant initial degradation pathways (Quintana et al., 2005) 437 
for the well removed compounds ibuprofen (97%) and ketoprofen (70%), respectively. It is, 438 
however, not clear why despite possessing the similar metabolic pathway as ketoprofen, 439 
triamterene registered a rather low removal of 28%. The absence of any literature data regarding 440 
triamterene removal by CAS or MBR restricts further clarification regarding this matter. The 441 
only possible distinction that can be offered at this stage is that triamterene is a heterocyclic 442 
compound. 443 
It is known that the degradation of compounds with an aromatic-aliphatic ether fragment can 444 
proceed by ether cleavage, producing phenol derivative and aldehyde (Bernhardt et al., 1988). Of 445 
the tested compounds that fit into this category gemfibrozil (98%) and verapamil (87%) were 446 
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well removed while omeprazol (62%) and naproxen (40%) demonstrated moderate removal, and 447 
trimethoprim was poorly removed (16%). The predominant biodegradation route of naproxen 448 
and trimethoprim appears to be via ether cleavage (Quintana et al., 2005); however, the 449 
degradation can potentially proceed via conversion of tertiary/secondary aliphatic to 450 
corresponding alcohol. On the other hand, in addition to the ether cleavage verapamil may be 451 
degraded by N-demethylation (Unadkat et al., 2008). The degradation of omeprazole can also 452 
initiate from the conversion of di-[C,O]-substituted sulfoxide to sulfone (Kanazawa et al., 2003), 453 
and gemfibrozil can be degraded also through conversion of aromatic methyl to primary alcohol 454 
(Hermening et al., 2000). The discrepancy in the removal rates of these compounds may, 455 
therefore, be attributed to the distinct alternate routes of biodegradation, which may govern the 456 
overall removal. 457 
The combined effect of functional groups and hydrophobicity on the removal of trace organic 458 
compounds by the MBR is shown in Figure 6. It is evident from the above discussion that all the 459 
aspects of chemical structure i.e., aromatic moiety, ring composition, substituent groups, side 460 
chain and associated metabolic pathway need to be taken into account in conjunction with 461 
physical parameters namely hydrophobicity and molecular weight to explain observed 462 
variabilities in trace organic removal by MBR.  463 
As noted earlier, in an MBR, adsorption and biodegradation may simultaneously play important 464 
roles. However, for the compounds with low hydrophobicity, properties such as molecular 465 
weight, ring structure and functional groups may influence the biodegradability and consequently 466 
govern the overall removal. Although some similarities can be expected, the purpose of this 467 
section is clearly not to describe the biodegradability of trace organics in biological wastewater 468 
treatment in general. The comprehensive discussion on biodegradability and metabolic pathway 469 
as furnished here serves the important purpose of explaining the removal of compounds with low 470 
hydrophobicity in the MBR.  471 
[FIGURE 6] 472 
3.3.4 A framework to predict removal efficiency 473 
Notwithstanding a few exceptions which will be subjected to further investigation, results 474 
reported in this study indicate a clear link between molecular features and the removal of trace 475 
organic compounds by MBR treatment. Figure 7, based on the data presented in this study, 476 
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outlines a qualitative and schematic framework for the prediction of the removal efficiency of 477 
any given compound by an aerobic MBR treatment process. Given the similarities between CAS 478 
and MBR treatment, the framework proposed here may also be applicable to CAS treatment 479 
processes to some extent. However, differences in operational conditions between MBR and 480 
CAS must be carefully considered. For example, because MBR usually operates at a much 481 
longer sludge retention time and can offer complete retention of the biomass, hydrophobicity of 482 
the trace organic compounds would have a more profound impact on their removal efficiency by 483 
MBR than that by CAS. For the compounds with low hydrophobicity, where biodegradability is 484 
likely to govern the overall removal, the performance of CAS operated under the same loading 485 
and sludge retention time may be comparable to MBR (Clara et al., 2005). However it also needs 486 
to be noted that MBR may facilitate growth and maintenance of special degrading microbes (Hai 487 
et al., 2010)  which may contribute to enhanced removal of compounds with low hydrophobicity. 488 
To derive further insight into this matter long-term investigation with the same set of data 489 
comparing the performance of CAS and MBR will need to be carried out. That, however, is 490 
beyond the scope of this study. It is prudent to note that this proposed framework has been based 491 
on a limited set of data of only 40 compounds. Nevertheless, this framework has the potential to 492 
provide significant insights to the removal of trace organic contaminants by MBR treatment. 493 
With ongoing scientific and dedicated efforts in this field, the framework can be a foundation for 494 
a future quantitative model for the prediction of trace organic removal by MBR and CAS 495 
treatment. 496 
[FIGURE 7] 497 
4 Conclusion 498 
Results reported in this study indicate an apparent correlation between molecular features and the 499 
removal of trace organic contaminants by a laboratory scale MBR system. The removal 500 
efficiencies of all 14 very hydrophobic trace organic compounds (Log D at pH 8 > 3.2) selected 501 
in this study consistently showed removal efficiencies in the range between 85% to removal to 502 
below the analytical detection limit, indicating a removal of at least 98%. The occurrence of 503 
electron withdrawing or electron donating functional groups appears to be another important 504 
factor governing their removal by MBR treatment. All hydrophilic and moderately hydrophobic 505 
(Log D < 3.2) compounds possessing strong electron withdrawing functional groups consistently 506 
19 
showed removal efficiency of well below 20%. In contrast, high removal efficiency was 507 
observed with most compounds bearing electron donating functional groups such as hydroxyl 508 
groups and primary amine groups. Nevertheless, further analysis also revealed several exceptions 509 
which remained unexplainable given the current lack of biochemical data about these compounds 510 
of interest. Based on the reported data, a qualitative framework for the assessment of trace 511 
organics removal by MBR treatment was presented. 512 
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LIST OF TABLES 684 
Table 1: Removal efficiencies of the selected trace organic contaminants (n=16) obtained in this 685 
investigation and corresponding values recorded in the literature. 686 
Class Compound 
This study (%) 
(Average ± Std) 
Literature (%)
(min – max) 
References a 
Pesticides 
Atrazine 4.4 ± 3.7 9 – 40 1,2 
Linuron 21.1 ± 4.1 not available  
DEET 4.6 ± 2.4 0 – 78 1, 3, 4 
Non-steroidal 
anti-
inflammatory 
Paracetamol 95.1 ± 3.4 ≥99 3, 5-7 
Ketoprofen 70.5 ± 0.8 43.9 – 95 5-6, 8-9 
Naproxen 40.1 ± 2.8 36 – 91.6 3, 5-7, 9-10 
Ibuprofen 96.7 ± 0.7 ≥90 1,3, 5-7, 9, 11-14 
Diclofenac 17.3 ± 4.2 0 – 87.4 1,3, 5,6, 9, 12, 13, 15, 16 
Anti-
depressants & 
mood 
stabilizers 
Clozapine 84.8 ± 5.4 not available  
Risperidone 95.8 ± 2.2 not available  
Primidone 12.4 ± 4.3 not available  
Carbamazepine 13.4 ± 4.3 0 – 13 1,5, 7, 11, 13, 17 
Dilantin 5.4 ± 3.6 0 – 12 4 
Amitriptyline 97.8 ± 0.8 not available  
Antibiotic & 
antiseptic 
Triclosan >91.8 61 – 95 3, 4 
Triclocarban >98.4 not available  
Sulfamethoxazole 91.9 ± 0.6 52 – 80.8 3,5,6, 11-13, 18 
Trimethoprim 16.6  ± 3.7 0 – 90 3, 6, 11, 18 
Hypolipidemic 
agents 
Simvastatin 97.9 ± 0.9 not available  
Gemfibrozil 98.95 ± 0.1 32.5 – 90 5, 6, 11 
Sim-hydroxyacid 59.6 ± 2.8 not available  
Cardiovascular 
drugs 
Atenolol 96.9 ± 0.2 70 5, 9 
Verapamil 88.4 ± 6.1 not available  
Enalapril 97.1 ± 0.1 not available  
Other drugs 
Triamterene 27.9 ± 6.3 not available  
Hydroxyzine >92.2 not available  
Meprobamate 14.5 ± 3.3 not available  
Caffeine 49.6 ± 4.1 98 – 99 3, 4 
Omeprazole 62.1 ± 3.5 not available  
Steroid 
hormones 
Estrone 98.0 ± 0.2 96.3 13, 19 
17β-estradiol >99.4 100 13, 19 
Androstenedione >99.5 not available  
Estriol 98.2 ± 1.9 >99 13 
Testosterone >99.4 not available  
Etiocholanolone >99.4 not available  
Androsterone >99.3 not available  
17α-ethynylestradiol 93.5 ± 1.2 81.9 – 93.6 19 
Other EDCs 
Bisphenol A 90.4 ± 3.1 68.9 – 99.0 10, 12, 13, 19, 20 
Nonyphenol 99.3 ± 0.2 0 – 88 12, 13, 21, 22 
t-octylphenol 94.5 ± 1.1 44.9 – 99.0 13 
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a References: 1(Bernhard et al., 2006); 2(Bouju et al., 2008); 3(Kim et al., 2007); 4(Snyder et al., 687 
2007); 5(Radjenovic et al., 2007); 6(Radjenovic et al., 2009); 7(Joss et al., 2005); 8(Kimura et al., 688 
2005); 9(Quintana et al., 2005); 10(Urase et al., 2005); 11(Reif et al., 2008); 12(Kreuzinger, 2004); 689 
13(Clara et al., 2005); 14(Smook et al., 2008); 15(Gonzalez et al., 2006); 16(Abegglen et al., 2009); 690 
17(Clara et al., 2004); 18(Göbel et al., 2007); 19(Lyko et al., 2005); 20(Chen et al., 2008); 21(Cirja 691 
et al., 2006); 22(Hu et al., 2007).  692 
693 
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LIST OF CAPTIONS 694 
Figure 1: Influent and effluent concentration of the selected trace organic contaminants. 695 
Samples were collected twice a week and in duplicate for four weeks. Error bars represent the 696 
standard deviation of 16 measurements. 697 
Figure 2: The relationship of removal of trace organic compounds with effective hydrophobicity 698 
(Log D). The MLSS pH during the experiment was 7.5±0.1. Log D values were obtained from 699 
the SciFinder Scholar (ACS) database. Error bars represent the standard deviation of 16 700 
measurements. 701 
Figure 3: Removal efficiency of trace organic compounds as a function of their molecular 702 
weight. Error bars represent the standard deviation of 16 measurements. 703 
Figure 4: Removal efficiency as a function of ring structure. Error bars represent the standard 704 
deviation of 16 measurements. 705 
Figure 5: Compound classification according to the presence of electron donating or 706 
withdrawing functional groups. 707 
Figure 6: The combined effects of functional group and hydrophobicity on the removal of trace 708 
organic compounds by the MBR. Error bars represent the standard deviation of 16 709 
measurements. Group A: all compounds with Log D > 3.2 (at pH 8). Groups B, C, and C* are 710 
defined in Figure 5.  711 
Figure 7: A qualitative framework for the prediction of trace organic removal by MBR 712 
treatment.713 
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Compound CAS number Formula 
MW 
(g/mol) 
Log Kow
  
Log D 
(at pH 8) 
pKa
  
Paracetamol 103-90-2 C8H9NO2 151.2 0.33 0.33 9.86; 1.72 
DEET 134-62-3 C12H17NO 191.3 1.95 1.96 -1.37 
Caffeine 58-08-2 C8H10N4O2 194.2 -0.13 -0.13 0.73 
Ibuprofen 15687-27-1 C13H18O2 206.3 3.72 0.36 4.41 
t-Octylphenol 140-66-9 C14H22O 206.3 4.93 4.93 10.15 
Atrazine 1912-24-9 C8H14ClN5 215.7 2.63 2.63 2.35 
Meprobamate 57-53-4 C9H18N2O4 218.3 0.70 0.70 13.09; -1.09 
Primidone 125-33-7 C12H14N2O2 218.3 0.40 0.40 12.26; -1.07 
Nonylphenol 104-40-5 C15H24O 220.4 6.19 6.19 10.14 
Bisphenol-A 80-05-7 C15H16O2 228.3 3.43 3.43 9.73 
Naproxen 22204-53-1 C14H14O3 230.3 3.00 -0.06 4.84 
Carbamazepine 298-46-4 C15H12N2O 236.3 2.67 2.67 13.94; -0.49 
Linuron 330-55-2 C9H10Cl2N2O2 249.1 3.20 3.20 12.13; -1.04 
Gemfibrozil 25812-30-0 C15H22O3 250.3 4.39 1.26 4.75 
Dilantin 57-41-0 C15H12N2O2 252.3 2.52 2.36 8.33; -2.81 
Triamterene 396-01-0 C12H11N7 253.3 1.34 1.33 6.30 
Sulfamethoxazole 723-46-6 C10H11N3O3S 253.3 0.89 -0.9 5.81; 1.39 
Ketoprofen 22071-15-4 C16H14O3 254.3 2.81 -0.64 4.23 
Atenolol 29122-68-7 C14H22N2O3 266.3 0.10 -1.09 13.88; 9.16 
Estrone 53-16-7 C18H22O2 270.4 3.69 3.68 10.25 
17-estradiol 50-28-2 C18H24O2 272.4 4.13 4.13 10.27 
Amtriptyline 50-48-6 C20H23N 277.4 4.92 3.72 9.18 
Androstenedione 63-05-8 C19H26O2 286.4 2.90 2.90 8.78 
Estriol 50-27-1 C18H24O3 288.4 2.94 2.94 10.25 
Testosterone 58-22-0 C19H28O2 288.4 3.47 3.47 15.06 
Triclosan 3380-34-5 C12H7Cl3O2 289.5 5.17 4.76 7.80 
Trimethoprim 738-70-5 C14H18N4O3 290.3 0.79 0.73 7.20 
Etiocholanolone 53-42-9 C19H30O2 290.4 3.75 3.75 15.13 
Androsterone 53-41-8 C19H30O2 290.4 3.93 3.93 15.14 
Diclofenac 15307-86-5 C14H11Cl2NO2 296.2 4.06 0.57 4.18; -2.25 
17-ethynylestradiol 57-63-6 C20H24O2 296.4 4.52 4.52 10.24 
Triclocarban 101-20-2 C13H9Cl3N2O 315.6 5.74 5.74 12.77; -0.34 
Clozapine 5786-21-0 C18H19ClN4 326.8 3.48 3.42 7.14 
Omeprazole 73590-58-6 C17H19N3O3S 345.4 2.17 2.04 8.46; 4.72 
Hydroxyzine 68-88-2 C21H27ClN2O2 374.9 2.03 2.02 14.41; 6.12 
Enalapril 75847-73-3 C20H28N2O5 376.5 2.43 -1.21 3.17; 5.43 
Risperidone 106266-06-2 C23H27FN4O2 410.5 2.88 2.63 7.89 
Simvastatin 79902-63-9 C25H38O5 418.6 4.41 4.41 13.49 
Sim-hydroxy acid 121009-77-6 C25 H40 O6 436.6 4.05 0.64 4.31 
Verapamil 52-53-9 C27H38N2O4 454.6 3.90 2.89 8.97 
 
Source: SciFinder Scholar, data calculated using Advanced Chemistry Development (ACD/Labs) Software V8.14 
for Solaris (1994-2007 ACD/Labs). 
